It’ll be at least a decade before the nanotech is commercial (if ever).
low cost dso kaolin is also low margin. Imo it’s a mediocre business model.. Adn won’t ever realise its full potential based on this. Would be interesting to see the scoping study numbers... what’s the delay for?
hpa jv- what jv? That asx market leader in this area is struggling to maintain share price, partly because actual demand isn’t living up to forecasts imo. Plus proven met work is a long way off.
all imo.
General comments/chat, page-1063
-
- There are more pages in this discussion • 43,282 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.87M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.6¢ | $2.139K | 129.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1009118 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 2695345 | 5 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| ADN (ASX) Chart |